Home ENGLISH

ENGLISH

Latest

Merck’s Ebola vaccine tees up FDA date, aiming for first status

admin -
0

Another failed midstage asset for Acceleron, another pipeline test dumped

admin -
0

Foghorn and Rgenix nab Agios, Roche veterans as new CMOs

admin -
0

ECTRIMS: Atara’s off-the-shelf T cells for EBV-driven MS show promise in small study

admin -
0

Prostate drug may slow Parkinson’s progression, big data suggest

admin -
0

J&J taps AlivaMab for multi-target antibody discovery effort

admin -
0

Lundbeck pens $2B Alder takeover to boost brain disease pipeline

admin -
0

The first ‘right-to-try’ CRO launches

admin -
0

Fierce 15: Where are they now?

admin -
0

Chutes & Ladders—Bayer trims 2 execs in corporate reshuffling

admin -
0

Biogen, Eisai throw out remaining Alzheimer’s BACE hope

admin -
0

Ritter’s microbiome modulator fails lactose intolerance phase 3 

admin -
0

Celgene’s phase 3 AML test chalks up a win

admin -
0

Amgen shares hit after analysts expose buried FDA trial halt

admin -
0

Moderna guides 2 mRNA assets through early clinical tests

admin -
0

Tocagen fails brain cancer test, sets about ‘operational review’ as shares routed

admin -
0

Roche’s satralizumab cuts relapse risk in rare disease phase 3

admin -
0

Penn team repurposes CAR-T cancer tech to treat heart disease

admin -
0
123...1,513Page 1 of 1,513
©